(Q36752048)

16 August 2017

1 reference

title

Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies (English)

1 reference

16 August 2017

John S Vorhies

1

1 reference

PubMed ID

17338656

16 August 2017

John Nemunaitis

series ordinal

2

1 reference

16 August 2017

1 March 2007

1 reference

Expert Review of Anticancer Therapy

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

373-382

1 reference

16 August 2017

3

1 reference

Direct gene transfer into mouse muscle in vivo

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Nonviral vectors in the new millennium: delivery barriers in gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

RNAi-mediated pathways in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Potential applications of RNA interference technology in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

RNA interference and the use of small interfering RNA to study gene function in mammalian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Nonviral approaches satisfying various requirements for effective in vivo gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Nonviral in vivo gene delivery into tumors using a novel low volume jet-injection technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Preferential liver gene expression with polypropylenimine dendrimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Tumor targeting with surface-shielded ligand--polycation DNA complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Targeted polymers for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Folate receptor-mediated drug targeting: from therapeutics to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Cancer-specific ligands identified from screening of peptide-display libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Aptamer therapeutics advance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Aptamers: an emerging class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Current status of polymeric gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Pegylated polyethylenimine-Fab' antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Dendrimers in gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

DNA complexing with polyamidoamine dendrimers: implications for transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

HER2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Polymeric nanostructures for drug delivery applications based on Pluronic copolymer systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Vector-mediated cancer gene therapy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Natural polymers for gene delivery and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Synthetic and natural polycations for gene therapy: state of the art and new perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Atelocollagen for protein and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Evaluation of collagen and methylated collagen as gene carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Delivery and expression of pDNA embedded in collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

DNA-polycation nanospheres as non-viral gene delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Chitosans for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Effects of structure of beta-cyclodextrin-containing polymers on gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Cyclodextrin-modified polyethylenimine polymers for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A modified process for preparing cationic polylactide-co-glycolide microparticles with adsorbed DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Cationic lipids, lipoplexes and intracellular delivery of genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Lipoplex formation under equilibrium conditions reveals a three-step mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Lipid carrier systems for targeted drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Brain-specific expression of an exogenous gene after i.v. administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Folate-targeted gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Intravenous, non-viral RNAi gene therapy of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Optimising non-viral gene delivery in a tumour spheroid model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Gene transfer by DNA/mannosylated chitosan complexes into mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Polymeric gene carrier for insulin secreting cells: poly(L-lysine)-g-sulfonylurea for receptor mediated transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Poly(L-lysine)-modified silica nanoparticles for the delivery of antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Collagen gel systems for sustained delivery and tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Gelatin as a delivery vehicle for the controlled release of bioactive molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Ligand-targeted liposomes for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

Inhalation delivery of manganese superoxide dismutase-plasmid/liposomes protects the murine lung from irradiation damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

A plasmid-encoded VEGF siRNA reduces glioblastoma angiogenesis and its combination with interleukin-4 blocks tumor growth in a xenograft mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.3.373

21 January 2018

Identifiers

DOI

10.1586/14737140.7.3.373

1 reference

16 August 2017

1 reference

PubMed ID

17338656